Company Details
Sector | PHARMACEUTICALS |
Address | 35 - Dockyard Road West Wharf Karachi |
Auditor | Yousuf Adil, Chartered Accountants |
Registrar | CDC Share Registrar Services Limited CDC House, 99 - B, Block - B S.M.C.H.S., Main Shahra-e-Faisal Karachi |
Website | www.pk.gsk.com |
Fiscal Year | December |
Details |
Details
GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V.@ incorporated in Netherlands@ whereas its ultimate parent company is GlaxoSmithKline plc@ UK (GSK plc).
Company Announcements
Date/Time | Announcement |
---|---|
26/10/2015 15:46:40 | FINANCIAL RESULT FOR THE NINE MONTHS ENDED 30/09/2015 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 2,699.852 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 1,974.852 EPS = 6.20 |
25/08/2015 15:07:25 | EPS = 2.61 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,210.640 FINANCIAL RESULT FOR THE HALF YEAR ENDED 30/06/2015 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 832.889 |
29/04/2015 14:48:12 | EPS = 1.46 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 465.658 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 774.311 FINANCIAL RESULT FOR THE FIRST QUARTER ENDED 31/03/2015 |
25/02/2015 15:51:50 | BOOK CLOSURE FROM 16/04/2015 FINANCIAL RESULT FOR THE YEAR ENDED 31/12/2014 DIVIDEND = 50% PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 2,848.582 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 1,687.071 EPS = 5.30 ANNUAL GENERAL MEETING WILL BE HELD ON 23/04/2015 BOOK CLOSURE TO 23/04/2015 |
21/10/2014 15:55:23 | EPS = 3.75 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 2,022.665 FINANCIAL RESULT FOR THE NINE MONTHS ENDED 30/09/2014 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 1,192.665 |